UK markets closed

Jaguar Health, Inc. (JAGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.2200-0.0700 (-1.63%)
At close: 04:00PM EDT
4.2900 +0.07 (+1.66%)
After hours: 07:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-39,711
-47,454
-52,595
-33,809
-38,539
Depreciation & amortisation
2,399
2,292
1,813
2,280
1,928
Stock-based compensation
1,933
3,318
3,974
2,824
2,989
Change in working capital
-10,090
-4,428
2,267
-3,467
-662
Accounts receivable
151
-170
2,823
-2,840
-696
Inventory
-1,778
-2,124
-2,118
-653
1,213
Accounts payable
-1,159
902
158
-743
-63
Other working capital
-32,575
-34,779
-34,976
-15,285
-20,457
Other non-cash items
14,798
12,581
5,187
6,572
5,896
Net cash provided by operating activities
-32,214
-33,104
-34,970
-15,278
-20,457
Cash flows from investing activities
Investments in property, plant and equipment
-
-1,675
-6
-7
-
Net cash used for investing activities
-361
-1,675
-6
-7
0
Cash flows from financing activities
Debt repayment
-32
-100
-1,922
-6,613
-5,150
Common stock issued
23,523
20,462
33,578
1,949
6,627
Common stock repurchased
-
-
-
-
0
Other financing activities
-122
-1,156
-731
6,049
-2,575
Net cash used provided by (used for) financing activities
25,215
23,181
43,937
19,492
21,772
Net change in cash
-7,335
-11,582
8,961
4,207
1,315
Cash at beginning of period
10,561
17,051
8,090
3,883
2,568
Cash at end of period
3,201
5,469
17,051
8,090
3,883
Free cash flow
Operating cash flow
-32,214
-33,104
-34,970
-15,278
-20,457
Capital expenditure
-
-1,675
-6
-7
-
Free cash flow
-32,575
-34,779
-34,976
-15,285
-20,457